RLYB

Rallybio Stock Analysis

AI Rating

Neutral
  • Quality5/10
  • Growth↑ 8/10
  • Value↓ 1/10
Rallybio sales and earnings growth
RLYB Growth
Good
  • Revenue Y/Y↑ 12.71%
  • EPS Y/Y↑ 79.84%
  • FCF Y/Y↑ 31.48%
Rallybio gross and profit margin trends
RLYB Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↓ -2102.40%
  • ROIC 5Y↓ -79.80%
Rallybio net debt vs free cash flow
RLYB Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Rallybio stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗